Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma

Cancer Science

Volumn 103, Issue 11, 2012, Pages 2021-2026

  Kashimoto, Kingo ^a   Komatsu, Shuhei ^a   Ichikawa, Daisuke ^a   Arita, Tomohiro ^a   Konishi, Hirotaka ^a   Nagata, Hiroaki ^a   Takeshita, Hiroki ^a   Nishimura, Yukihisa ^a   Hirajima, Shoji ^a   Kawaguchi, Tsutomu ^a   Shiozaki, Atsushi ^a   Fujiwara, Hitoshi ^a   Okamoto, Kazuma ^a   Tsuda, Hitoshi ^b   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RING FINGER PROTEIN; SMALL INTERFERING RNA; TRIPARTITE MOTIF CONTAINING PROTEIN 44; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TRIPARTITE MOTIF CONTAINING PROTEIN 44 GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARRIER PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84868207736     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02407.x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Martin RC II, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg 2002; 236: 159-65.
3. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004; 5: 121-5.
4. Maesawa C, Tamura G, Suzuki Y et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 1995; 176: 249-58.
5. Becker KF, Atkinson MJ, Reich U et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52.
6. Lee JH, Abraham SC, Kim HS et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002; 161: 611-8.
7. Park WS, Oh RR, Park JY et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 4257-60.
8. Fang DC, Wang RQ, Yang SM et al. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003; 9: 655-9.
9. Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of p16 gene in gastric cancer. World J Gastroenterol 2003; 9: 423-6.
10. Oue N, Motoshita J, Yokozaki H et al. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 2002; 198: 55-9.
11. Weissman AM. Regulating protein degradation by ubiquitination. Immunol Today 1997; 18: 189-98.
12. Koepp DM, Schaefer LK, Ye X et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 2001; 294: 173-7.
13. Tsunematsu R, Nakayama K, Oike Y et al. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J Biol Chem 2004; 279: 9417-23.
14. Onoyama I, Tsunematsu R, Matsumoto A et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204: 2875-88.
15. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11: 792-804.
16. Boutou E, Matsas R, Mamalaki A. Isolation of a mouse brain cDNA expressed in developing neuroblasts and mature neurons. Brain Res Mol Brain Res 2001; 86: 153-67.
17. Jarvinen AK, Autio R, Kilpinen S et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosom Cancer 2008; 47: 500-9.
18. Peters CJ, Rees JR, Hardwick RH et al. A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 2010; 139: 1995-2004.e15.
19. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumors, 7th edn. New York: Wiley-liss, 2009.
20. Komatsu S, Imoto I, Tsuda H et al. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis 2009; 30: 1139-46.
21. Naoi Y, Miyoshi Y, Taguchi T et al. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett 2008; 262: 248-56.
22. Tsuda H. Individualization of breast cancer based on histopathological features and molecular alterations. Breast Cancer (Tokyo, Japan) 2008; 15: 121-32.
23. Reymond A, Meroni G, Fantozzi A et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-51.
24. Ozato K, Shin DM, Chang TH, Morse HC III. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 2008; 8: 849-60.
25. McNab FW, Rajsbaum R, Stoye JP, O'Garra A. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 2011; 23: 46-56.
26. Yokoe T, Toiyama Y, Okugawa Y et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol 2010; 17: 821-8.
27. Kosaka Y, Inoue H, Ohmachi T et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol 2007; 14: 2543-9.
28. Sugiura T, Miyamoto K. Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein. J Cell Biochem 2008; 105: 1081-91.
29. Sugiura T. The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol Int 2011; 35: 657-61.
30. Li Z, Na X, Wang D, Schoen SR, Messing EM, Wu G. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J Biol Chem 2002; 277: 4656-62.
31. Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem Biophys Res Commun 2002; 294: 700-9.
32. Li Z, Wang D, Messing EM, Wu G. VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha. EMBO Rep 2005; 6: 373-8.